---
$id: https://graph.org.ai/products/commodity/51151622
$type: Product
source: UNSPSC
code: "51151622"
title: "Bevonium"
class: "51151600"
classTitle: "Cholinergic blocking agents"
family: "51150000"
familyTitle: "Autonomic nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Bevonium

**UNSPSC Code**: 51151622
**Class**: [Cholinergic blocking agents](Cholinergic blocking agents.mdx)
**Family**: [Autonomic nervous system drugs](../Autonomic nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anticholinergic agent with the molecular formula C22H28NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 34B0471E08, chemically known as 2-(hydroxymethyl)-n,n-dimethylpiperidinium methyl sulfate benzilate but generally known as bevonium, which bears US NIH Compound Identifier 31800. bevonium most often comes in base and methyl sulfate forms, also called methylsulfate, methylsulphate, or even metilsulfate. European Medicines Agency schedules Bevonium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00794MIG. World Health Organization schedules bevonium in its Anatomical Therapeutic Chemical (ATC) Classification. BEVONIUM is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. As of Q4 2014, BEVONIUM remains the US FDA Preferred Term for this commodity. Bevonium bears US NLM identifiers UMLS ID C0053533 and NCI Concept Code C73804. SMILES: O(CC1[N](CCCC1)(C)C)C(=O)C(O)(C1CCCCC1)C1CCCCC1. .

